Gilead Sciences Inc (GILD)
89.80
+1.17
(+1.32%)
USD |
NASDAQ |
Nov 21, 16:00
89.80
0.00 (0.00%)
After-Hours: 18:13
Gilead Sciences Shareholders Equity (Quarterly): 18.47B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 18.47B |
June 30, 2024 | 18.28B |
March 31, 2024 | 17.54B |
December 31, 2023 | 22.83B |
September 30, 2023 | 22.31B |
June 30, 2023 | 21.16B |
March 31, 2023 | 21.00B |
December 31, 2022 | 21.24B |
September 30, 2022 | 21.08B |
June 30, 2022 | 20.24B |
March 31, 2022 | 19.93B |
December 31, 2021 | 21.07B |
September 30, 2021 | 21.47B |
June 30, 2021 | 19.70B |
March 31, 2021 | 18.95B |
December 31, 2020 | 18.20B |
September 30, 2020 | 17.44B |
June 30, 2020 | 18.03B |
March 31, 2020 | 22.07B |
December 31, 2019 | 22.52B |
September 30, 2019 | 20.60B |
June 30, 2019 | 22.62B |
March 31, 2019 | 21.95B |
December 31, 2018 | 21.39B |
September 30, 2018 | 22.86B |
Date | Value |
---|---|
June 30, 2018 | 21.67B |
March 31, 2018 | 20.59B |
December 31, 2017 | 20.44B |
September 30, 2017 | 24.84B |
June 30, 2017 | 22.68B |
March 31, 2017 | 20.44B |
December 31, 2016 | 18.89B |
September 30, 2016 | 16.87B |
June 30, 2016 | 15.54B |
March 31, 2016 | 13.40B |
December 31, 2015 | 18.53B |
September 30, 2015 | 17.41B |
June 30, 2015 | 16.29B |
March 31, 2015 | 17.18B |
December 31, 2014 | 15.43B |
September 30, 2014 | 13.57B |
June 30, 2014 | 16.09B |
March 31, 2014 | 13.39B |
December 31, 2013 | 11.37B |
September 30, 2013 | 10.88B |
June 30, 2013 | 11.09B |
March 31, 2013 | 10.15B |
December 31, 2012 | 9.303B |
September 30, 2012 | 8.604B |
June 30, 2012 | 8.002B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
17.44B
Minimum
Sep 2020
22.83B
Maximum
Dec 2023
20.18B
Average
20.62B
Median
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 14.24B |
Merck & Co Inc | 44.50B |
Pfizer Inc | 92.29B |
Vertex Pharmaceuticals Inc | 15.63B |
Amgen Inc | 7.527B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 54.52B |
Total Liabilities (Quarterly) | 36.14B |
Debt to Equity Ratio | 1.258 |
Current Ratio | 1.261 |
Net Debt Paydown Yield | 0.38% |